Geptanolimab, CAS 2348469-43-0

Product Description: Geptanolimab (CBT-501) is a humanized IgG4k monoclonal antibody against programmed death-1 (PD-1). Siplizumab inhibits the binding of PD-L1/L2 to PD-1 through a competitive action. Siplizumab can be used in research of cancer[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Qing Z, et, al. Activity of CBT-501, a novel humanized anti-PD-1 antibody, in a humanized genetically engineered mouse model of colon carcinoma. Journal of Clinical Oncology. 2017;35 (7_suppl):108-108.

CAS Number: 2348469-43-0

Molecular Weight: N/A

Compound Purity: 97.72

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: PD-1/PD-L1

• Artikelnummer: MEXHY-P99639-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99639-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated